Evidence map›Paper›PMID 41466901›Full record

ArticleCureus2025

Parry-Romberg Syndrome Associated With En Coup De Sabre: A Clinical Case Report.

Gabija Dragunaite, Gabriele Vengalyte, Jurgita Makstiene, Arūnas Petkevičius, Agne Panaviene

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabija DragunaiteDepartment of Skin and Venereal Diseases, Medical Academy, Lithuanian University of Health Sciences (LSMU), Kaunas, LTU.
Gabriele VengalyteDepartment of Dermatology, Hospital of Lithuanian University of Health Sciences (LSMU) Kauno Klinikos, Kaunas, LTU.
Jurgita MakstieneDepartment of Pathology, Medical Academy, Lithuanian University of Health Sciences (LSMU), Kaunas, LTU.
Arūnas PetkevičiusDepartment of Skin and Venereal Diseases, Medical Academy, Lithuanian University of Health Sciences (LSMU), Kaunas, LTU.
Agne PanavieneDepartment of Skin and Venereal Diseases, Medical Academy, Lithuanian University of Health Sciences (LSMU), Kaunas, LTU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parry-Romberg syndrome (PRS), also known as progressive facial hemiatrophy, is a rare neurocutaneous disorder characterized by progressive, unilateral atrophy of the facial tissues. It usually appears during childhood or early adulthood; however, adult-onset cases are increasingly being recognized. PRS significantly overlaps with localized scleroderma, especially the en coup de sabre (ECDS) subtype, indicating a common pathophysiological mechanism. We present a 52-year-old female patient with adult-onset PRS associated with ECDS. The patient was first diagnosed with localized scleroderma in 1999, when she developed subtle atrophic changes in the right side of her face. Over two decades, the atrophy gradually advanced, leading to marked facial asymmetry. Re-evaluation in 2023 showed right hemifacial atrophy with a linear "sword stroke" lesion over the forehead that is a characteristic of ECDS. Laboratory tests, imaging, ophthalmologic evaluation, and skin biopsies confirmed PRS with linear scleroderma. To address the progressive functional and aesthetic impairments, systemic treatment with methotrexate was initiated to halt disease progression, with regular follow-ups scheduled for monitoring. This rare case of adult-onset PRS evolving from localized scleroderma highlights the need for high clinical suspicion in adults with progressive hemifacial atrophy, especially with ECDS. Early diagnosis and timely immunosuppressive treatment are crucial to limit disease progression and maximize patient outcomes.

Indexed as

autoimmune diseaseen coup de sabrelocalized sclerodermaparry-rombergprogressive hemifacial atrophy

Identifiers

PMID41466901
PMCPMC12744352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.